Related references
Note: Only part of the references are listed.Process and operations strategies to enable global access to antibody therapies
Brian Kelley et al.
BIOTECHNOLOGY PROGRESS (2021)
Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product
Lucia F. Zacchi et al.
COMMUNICATIONS BIOLOGY (2021)
Perfusion process combining low temperature and valeric acid for enhanced recombinant factor VIII production
Juliana Coronel et al.
BIOTECHNOLOGY PROGRESS (2020)
Stress Factors in mAb Drug Substance Production Processes: Critical Assessment of Impact on Product Quality and Control Strategy
Tapan K. Das et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Identification of novel glycosylation events on human serum-derived factor IX
Cassandra L. Pegg et al.
GLYCOCONJUGATE JOURNAL (2020)
Consequences of trace metal variability and supplementation on Chinese hamster ovary (CHO) cell culture performance: A review of key mechanisms and considerations
Ryan J. Graham et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Impact of cell culture media additives on IgG glycosylation produced in Chinese hamster ovary cells
Janike Ehret et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Dissecting N-Glycosylation Dynamics in Chinese Hamster Ovary Cells Fed-batch Cultures using Time Course Omics Analyses
Madhuresh Sumit et al.
ISCIENCE (2019)
Manipulation of the sodium-potassium ratio as a lever for controlling cell growth and improving cell specific productivity in perfusion CHO cell cultures
Samantha B. Wang et al.
BIOTECHNOLOGY AND BIOENGINEERING (2018)
Impact of CHO Metabolism on Cell Growth and Protein Production: An Overview of Toxic and Inhibiting Metabolites and Nutrients
Sara Pereira et al.
BIOTECHNOLOGY JOURNAL (2018)
The Coming Age of Insect Cells for Manufacturing and Development of Protein Therapeutics
Christine M. Yee et al.
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH (2018)
Application of maltose as energy source in protein-free CHO-K1 culture to improve the production of recombinant monoclonal antibody
Dawn Sow Zong Leong et al.
SCIENTIFIC REPORTS (2018)
Impact of CHO Metabolism on Cell Growth and Protein Production: An Overview of Toxic and Inhibiting Metabolites and Nutrients
Sara Pereira et al.
BIOTECHNOLOGY JOURNAL (2018)
Cell culture media for recombinant protein expression in Chinese hamster ovary (CHO) cells: History, key components, and optimization strategies
Frank V. Ritacco et al.
BIOTECHNOLOGY PROGRESS (2018)
Impact of host cell line choice on glycan profile
Justin Bryan Goh et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2018)
Effect of Propeptide Amino Acid Substitution in γ-Carboxylation, Activity and Expression of Recombinant Human Coagulation Factor IX
Jafar Vatandoost et al.
BIOTECHNOLOGY PROGRESS (2018)
Gene therapy for hemophilia: what does the future hold?
Bhavya S. Doshi et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2018)
Uridine modulates monoclonal antibody charge heterogeneity in Chinese hamster ovary cell fed-batch cultures
Huijie Niu et al.
BIORESOURCES AND BIOPROCESSING (2018)
Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B
Wolfgang Miesbach et al.
BLOOD (2018)
pH excursions impact CHO cell culture performance and antibody N-linked glycosylation
Rubin Jiang et al.
BIOPROCESS AND BIOSYSTEMS ENGINEERING (2018)
Cell culture media supplemented with raffinose reproducibly enhances high mannose glycan formation
David Bruhlmann et al.
JOURNAL OF BIOTECHNOLOGY (2017)
Investigation of O-glycosylation heterogeneity of recombinant coagulation factor IX using LC-MS/MS
Youngsuk Seo et al.
BIOANALYSIS (2017)
Production of recombinant coagulation factors: Are humans the best host cells?
Kamilla Swiech et al.
BIOENGINEERED (2017)
Evaluation and use of disaccharides as energy source in protein-free mammalian cell cultures
Dawn Sow Zong Leong et al.
SCIENTIFIC REPORTS (2017)
Understanding of decreased sialylation of Fc-fusion protein in hyperosmotic recombinant Chinese hamster ovary cell culture: N-glycosylation gene expression and N-linked glycan antennary profile
Jong Hyun Lee et al.
BIOTECHNOLOGY AND BIOENGINEERING (2017)
The enhancement of antibody concentration and achievement of high cell density CHO cell cultivation by adding nucleoside
Yasuhiro Takagi et al.
CYTOTECHNOLOGY (2017)
Cell culture media supplementation of infrequently used sugars for the targeted shifting of protein glycosylation profiles
Patrick Hossler et al.
BIOTECHNOLOGY PROGRESS (2017)
Impact of sodium butyrate and mild hypothermia on metabolic and physiological behaviour of CHO TF 70R cells
Veronica Avello et al.
ELECTRONIC JOURNAL OF BIOTECHNOLOGY (2017)
Valeric acid induces cell cycle arrest at G1 phase in CHO cell cultures and improves recombinant antibody productivity
Jin Hyoung Park et al.
BIOTECHNOLOGY JOURNAL (2016)
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Jennifer Dumont et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2016)
Valeric acid induces cell cycle arrest at G1 phase in CHO cell cultures and improves recombinant antibody productivity
Jin Hyoung Park et al.
BIOTECHNOLOGY JOURNAL (2016)
Valeric acid supplementation combined to mild hypothermia increases productivity in CHO cell cultivations
Juliana Coronel et al.
BIOCHEMICAL ENGINEERING JOURNAL (2016)
Mannose metabolism in recombinant CHO cells and its effect on IgG glycosylation
Peter G. Slade et al.
BIOTECHNOLOGY AND BIOENGINEERING (2016)
Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial
Elena Santagostino et al.
BLOOD (2016)
Identification of Novel N-Glycosylation Sites at Noncanonical Protein Consensus Motifs
Mark S. Lowenthal et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Structural and functional insights into enzymes of the vitamin K cycle
J. -K. Tie et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Industrial production of clotting factors: Challenges of expression, and choice of host cells
Sampath R. Kumar
BIOTECHNOLOGY JOURNAL (2015)
Functional expression of the human coagulation factor IX using heterologous signal peptide and propeptide sequences in mammalian cell line
Shohreh Khorshidi et al.
BIOTECHNOLOGY LETTERS (2015)
Continuous and semi-continuous cell culture for production of blood clotting factors
Sunil G. Desai
JOURNAL OF BIOTECHNOLOGY (2015)
Galactose supplementation enhance sialylation of recombinant Fc-fusion protein in CHO cell: an insight into the role of galactosylation in sialylation
Jintao Liu et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2015)
Effects of N-glycosylation on protein conformation and dynamics: Protein Data Bank analysis and molecular dynamics simulation study
Hui Sun Lee et al.
SCIENTIFIC REPORTS (2015)
Industrial production of clotting factors: Challenges of expression, and choice of host cells
Sampath R. Kumar
BIOTECHNOLOGY JOURNAL (2015)
Optimizing Chinese hamster ovary cell line development via targeted control of N-glycosylation
Christina S. Alves et al.
Pharmaceutical Bioprocessing (2015)
Dynamics of growth and metabolism controlled by glutamine availability in Chinese hamster ovary cells
Judith Wahrheit et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: A computational protein-protein docking and molecular dynamics refinement study
Divi Venkateswarlu
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial
Peter W. Collins et al.
BLOOD (2014)
Trehalose suppresses antibody aggregation during the culture of Chinese hamster ovary cells
Masayoshi Onitsuka et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2014)
Effects of nutrient levels and average culture pH on the glycosylation pattern of camelid-humanized monoclonal antibody
Hengameh Aghamohseni et al.
JOURNAL OF BIOTECHNOLOGY (2014)
The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody
Bo Liu et al.
JOURNAL OF BIOTECHNOLOGY (2014)
Identification of protein O-glycosylation site and corresponding glycans using liquid chromatography-tandem mass spectrometry via mapping accurate mass and retention time shift
Li-Juan Huang et al.
JOURNAL OF CHROMATOGRAPHY A (2014)
Improved Expression of Recombinant Human Factor IX by Co-expression of GGCX, VKOR and Furin
Jianming Liu et al.
PROTEIN JOURNAL (2014)
Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates
Robert Klamroth et al.
TRANSFUSION (2014)
The impact of process temperature on mammalian cell lines and the implications for the production of recombinant proteins in CHO cells
Rosalyn J. Masterton et al.
PHARMACEUTICAL BIOPROCESSING (2014)
Overview of the coagulation system
Sanjeev Palta et al.
INDIAN JOURNAL OF ANAESTHESIA (2014)
N-linked protein glycosylation in the ER
Markus Aebi
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Optimized signal peptides for the development of high expressing CHO cell lines
Lars Kober et al.
BIOTECHNOLOGY AND BIOENGINEERING (2013)
Metabolic analysis of antibody producing CHO cells in fed-batch production
Jason Dean et al.
BIOTECHNOLOGY AND BIOENGINEERING (2013)
Glycoengineered factor IX variants with improved pharmacokinetics and subcutaneous efficacy
A. R. Brooks et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B
P. M. Rallapalli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Differential investigations from plasma-derived and recombinant Factor IX revealed major differences in post-translational modifications of activation peptides
G. Chevreux et al.
VOX SANGUINIS (2013)
The CDC Hemophilia B mutation project mutation list: a new online resource
Tengguo Li et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2013)
Expression of biologically active human clotting factor IX in Drosophila S2 cells: ?-carboxylation of a human vitamin K-dependent protein by the insect enzyme
Jafar Vatandoost et al.
BIOTECHNOLOGY PROGRESS (2012)
Hyperglycosylation prolongs the circulation of coagulation factor IX
G. Bolt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Human hepatoma cell line HuH-7 is an effective cellular system to produce recombinant factor IX with improved post-translational modifications
Nathalie Enjolras et al.
THROMBOSIS RESEARCH (2012)
Coagulation Factor IX for Hemophilia B Therapy
N. A. Orlova et al.
ACTA NATURAE (2012)
Stable and high-level production of recombinant Factor IX in human hepatic cell line
Andrielle de Castilho Femandes et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2011)
Modulation of Antibody Galactosylation Through Feeding of Uridine, Manganese Chloride, and Galactose
Michael J. Gramer et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
The combined effect of sodium butyrate and low culture temperature on the production, sialylation, and biological activity of an antibody produced in CHO cells
Fei Chen et al.
BIOTECHNOLOGY AND BIOPROCESS ENGINEERING (2011)
Functional study of the vitamin K cycle in mammalian cells
Jian-Ke Tie et al.
BLOOD (2011)
Glycosylation of Therapeutic Proteins An Effective Strategy to Optimize Efficacy
Ricardo J. Sola et al.
BIODRUGS (2010)
γ-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function
Shmuel Gillis et al.
PROTEIN SCIENCE (2010)
Activation mechanisms of coagulation factor IX
Thomas Zoegg et al.
BIOLOGICAL CHEMISTRY (2009)
Identification of Cell Culture Conditions to Control N-Glycosylation Site-Occupancy of Recombinant Glycoproteins Expressed in CHO Cells
Martin Gawlitzek et al.
BIOTECHNOLOGY AND BIOENGINEERING (2009)
Optimal and consistent protein glycosylation in mammalian cell culture
Patrick Hossler et al.
GLYCOBIOLOGY (2009)
Asparagine-linked Oligosaccharides Present on a Non-consensus Amino Acid Sequence in the CH1 Domain of Human Antibodies
John F. Valliere-Douglass et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Effect of Ca2+ and Mg2+ concentration in culture medium on the activation of recombinant factor IX produced in Chinese hamster ovary cells
Won Hee Kim et al.
JOURNAL OF BIOTECHNOLOGY (2009)
Increasing the Sialylation of Therapeutic Glycoproteins: The Potential of the Sialic Acid Biosynthetic Pathway
Kaya Bork et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Valproic acid: A viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures
Gaurav Backliwal et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Effect of Culture Temperature on Erythropoietin Production and Glycosylation in a Perfusion Culture of Recombinant CHO Cells
Woo Suk Ahn et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
CHO cells adapted to hypothermic growth produce high yields of recombinant β-interferon
Kevin Sunley et al.
BIOTECHNOLOGY PROGRESS (2008)
Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk
Geun-Cheol Gil et al.
GLYCOBIOLOGY (2008)
Snake-venom-derived factor IX-binding protein specifically blocks the γ-carboxyglutamic acid-rich-domain-mediated membrane binding of human factors IX and X
Subash C. B. Gopinath et al.
BIOCHEMICAL JOURNAL (2007)
Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system
Christopher K. Crowell et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
The interface between the EGF2 domain and the protease domain in blood coagulation factor IX contributes to factor VIII binding and factor X activation
Caroline Fribourg et al.
BIOCHEMISTRY (2006)
Process parameter shifting:: Part I.: Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors
Evelyn Trummer et al.
BIOTECHNOLOGY AND BIOENGINEERING (2006)
The effect of dissolved oxygen on the production and the glycosylation profile of recombinant human erythropoietin produced from CHO cells
Veronica Restelli et al.
BIOTECHNOLOGY AND BIOENGINEERING (2006)
Functional analysis of the factor IX epidermal growth factor-like domain mutation Ile66Thr associated with mild hemophilia B
Karin E. Knobe et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2006)
Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by mammalian cell systems
M. Butler
CYTOTECHNOLOGY (2006)
Enhanced production of monomeric interferon-ss by CHO cells through the control of culture conditions
J Rodriguez et al.
BIOTECHNOLOGY PROGRESS (2005)
An important role for the activation peptide domain in controlling factor IX levels in the blood of haemophilia B mice
ME Begbie et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Post-translational modifications in proteins involved in blood coagulation
K Hansson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle
N Wajih et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effect of sodium butyrate on the production, heterogeneity and biological activity of human thrombopoietin by recombinant Chinese hamster ovary cells
YH Sung et al.
JOURNAL OF BIOTECHNOLOGY (2004)
Warfarin and the vitamin K-dependent γ-carboxylation system
R Wallin et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein
Y Shikamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Functional analysis of the EGF-like domain mutations Pro55Ser and Pro55Leu, which cause mild hemophilia B
KE Knobe et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Carboxylase overexpression effects full carboxylation but poor release and secretion of factor IX: Implications for the release of vitamin K-dependent proteins
KW Hallgren et al.
BIOCHEMISTRY (2002)
Vitamin K 2,3-epoxide reductase and the vitamin K-dependent γ-carboxylation system
R Wallin et al.
THROMBOSIS RESEARCH (2002)
The N-terminal epidermal growth factor-like domain of coagulation factor IX -: Probing its functions in the activation of factor IX and factor X with a monoclonal antibody
KEM Persson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding factor X activating complex
FH Wilkinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms
M Yang et al.
BIOTECHNOLOGY PROGRESS (2002)
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
DA Roth et al.
BLOOD (2001)
Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells
AE Hills et al.
BIOTECHNOLOGY AND BIOENGINEERING (2001)
Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells
KN Baker et al.
BIOTECHNOLOGY AND BIOENGINEERING (2001)
Involvement of mitochondrial permeability transition and caspase-9 activation in dimethyl sulfoxide-induced apoptosis of EL-4 lymphoma cells
J Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Posttranslational modifications of recombinant myotube-synthesized human factor IX
VR Arruda et al.
BLOOD (2001)
Enhanced γ-carboxylation of recombinant factor X using a chimeric construct containing the prothrombin propeptide
RM Camire et al.
BIOCHEMISTRY (2000)
Structural analysis of N-linked sugar chains of human blood clotting factor IX
Y Makino et al.
JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
